NEW YORK, July 16, 2015 /PRNewswire/ -- OTC Markets Group Inc. ("OTC Markets Group" or "the Company") (OTCQX: OTCM) today announced the second quarter 2015 performance and quarterly rebalancing of the OTCQX® indexes, the OTCQB® Venture Index, the OTCM QX ADR Index ("OTCQX30") and the OTCM ADR Index.
The OTCQX Composite Index (.OTCQX), which tracks the overall performance of the OTCQX Best Market, declined 3.9% in the second quarter. Forty companies were added to the Index during the quarter and 40 companies were removed, including Concordia Healthcare Corporation (NASDAQ : CXRX ), a Canada-based diverse healthcare company, which graduated from OTCQX to the Nasdaq stock exchange on June 29; Cynapsus Therapeutics Inc. (NASDAQ : CYNA ), a specialty pharmaceutical company, which moved to Nasdaq on June 18; and Real Industry, Inc. (NASDAQ : RELY ), which listed on Nasdaq on June 21.
The OTCQX Billion+ Index (.OTCQXBIL), a benchmark for OTCQX companies with a $1 billion market capitalization or greater, fell 4.0% during the quarter. Four companies were added to the index during the quarter and five were removed, including exchange graduate Concordia Healthcare.
The OTCQX Banks Index (.OTCQXBK), comprised of community and regional banks traded on OTCQX, rose 5.1% during the quarter. Sixteen companies were added to the index and eight companies were removed.
The OTCQX International Index (.OTCQXINT), a benchmark for international companies traded on OTCQX, was flat for the quarter. Eighteen companies were added to the index during the quarter and 27 companies were removed, including exchange graduates Concordia Healthcare and Cynapsus Therapeutics.
The OTCQX U.S. Index (.OTCQXUS), a benchmark for U.S.-domiciled OTCQX companies, gained 5.1% in the second quarter. Twenty-two companies were added to the index and 13 companies were deleted, including exchange graduate Real Industry.
The OTCQB Venture Index (.OTCQB), which tracks the overall performance of the OTCQB Venture Market, declined 5.1% in the second quarter. Three hundred and twenty-eight companies were added to the index during the quarter as more companies were approved to trade on OTCQB under the stricter market standards and eligibility requirements. Eighty-three companies were removed from the index during the quarter, including Cemtrex, Inc. (NASDAQ : CETX ), Pieris Pharmaceuticals, Inc. (NASDAQ : PIRS ), Corbus Pharmaceuticals Holdings Inc. (NASDAQ : CRBP ) and OncoSec Medical Incorporated (NASDAQ : ONCS ), which graduated to Nasdaq, and BioPharmX Corporation (NYSE MKT: BPMX), which moved to the NYSE MKT market.
The OTCQX30 Index (.OTCQX30), powered by BNY Mellon DR IndicesSM and comprised of the 30 largest, most actively-traded American Depositary Receipts (ADRs) on OTCQX, slipped 1.3% in the second quarter. Two companies were added to the index and two companies were removed.
The OTCM ADR Index (.OTCDR) powered by BNY Mellon DR Indices and comprised of ADRs traded on the OTCQX, OTCQB and OTC Pink® Markets, was flat for the quarter. Nine companies were added to the index during the quarter and 28 companies were removed.
For a list of all index additions and deletions, click here.
All indexes are market capitalization-weighted and are adjusted on a quarterly basis for additions and shares changes over 5% during the months of March, June, September and December. In the case of ADRs, the DR ratio is considered. Dividends are re-invested as of the close of business the day before the ex-dividend date.
The OTCQX Composite Index, OTCQX Billion+ Index, OTCQX International Index, OTCQX U.S. Index, OTCQX Banks Index and OTCQB Composite Index have a minimum liquidity screen to ensure tradability.
All index data is priced in real-time and is available on the OTC Markets Group website, www.otcmarkets.com, and via major financial data distributors and websites including Bloomberg, Reuters and FT.com.
Past performance does not guarantee future results. Investors cannot invest directly in any of these indexes.
OTC Markets Group Inc. provides no advice, recommendation or endorsement with respect to any company or securities. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, email@example.com
SOURCE OTC Markets Group Inc.